Latest in Pulmonary Embolism Management

Monday, March 9, 2026

2:18 PM - 2:26 PM EST

Location: Jefferson

Speaker(s)

Robert Lookstein, MD

Professor of Radiology & Surgery Vice Chair, Interventional Services
Icahn School of Medicine at Mount Sinai
New York, New York, United States

Disclosure(s): Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Innova: Stock Options [in privately held companies] (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Summa Therapeutics: Stock-privately held company (Ongoing); Thrombolex: Stock Options [in privately held companies] (Ongoing)

Disclosure(s):

Robert Lookstein, MD: Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Innova: Stock Options [in privately held companies] (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Summa Therapeutics: Stock-privately held company (Ongoing); Thrombolex: Stock Options [in privately held companies] (Ongoing)